Keenova Therapeutics plc: all 247 studies

Page 1 of 3. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT)Not yet recruitingNCT07846280Phase 3
• Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)RecruitingNCT07759362Phase 3
• StrataGraft Safety, Tolerability and Efficacy in Pediatric SubjectsCompletedNCT05517902Phase 3Results posted
• Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the ButtocksCompletedNCT05419505Phase 2Results posted
• Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar FibromatosisCompletedNCT05152173Phase 2Results posted
• StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal BurnsTerminatedNCT04765202Phase 1/2Results posted
• Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock CelluliteCompletedNCT04677712Phase 4Results posted
• CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection TechniquesCompletedNCT04580303Phase 2Results posted
• Safety and Efficacy of EN3835 in Participants With Frozen ShoulderCompletedNCT04496167Phase 2Results posted
• A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With HypogonadismCompletedNCT04456296Phase 4Results posted
• Histopathology Following CCH InjectionCompletedNCT04236635Phase 2Results posted
• Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult WomenTerminatedNCT04209530Phase 2Results posted
• Real World CCH Study in Adult Females With CelluliteCompletedNCT04170296Phase 3Results posted
• Impact of Acthar on Everyday Life of Participants With Severe KeratitisCompletedNCT04169061Phase 4Results posted
• StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT )CompletedNCT04123548Phase 3Results posted
• MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)CompletedNCT03712280Phase 2Results posted
• Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFPCompletedNCT03675685Phase 1Results posted
• Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)TerminatedNCT03656692Phase 4Results posted
• Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)CompletedNCT03632993Phase 2Results posted
• Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)CompletedNCT03526549Phase 3Results posted
• Effectiveness and Safety of EN3835 in the Treatment of Cellulite in WomenCompletedNCT03446781Phase 3Results posted
• Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in WomenCompletedNCT03428750Phase 3Results posted
• A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular DystrophyTerminatedNCT03400852Phase 2Results posted
• Safety and Effectiveness of EN3835 in the Treatment of EFP in WomenCompletedNCT03329989Phase 2Results posted
• Acthar Gel in Participants With Pulmonary SarcoidosisCompletedNCT03320070Phase 4Results posted
• Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)TerminatedNCT03126760Phase 4Results posted
• Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to PlaceboCompletedNCT03097861Phase 3Results posted
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT03068754Phase 2/3Results posted
• Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy VolunteersCompletedNCT03010631Phase 3Results posted
• StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal ElementsCompletedNCT03005106Phase 3Results posted
• StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin DefectsTerminatedNCT03005054Phase 2Results posted
• Acthar Gel for Active Systemic Lupus Erythematosus (SLE)CompletedNCT02953821Phase 4Results posted
• EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT02942160Phase 2Results posted
• Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid ArthritisCompletedNCT02919761Phase 4Results posted
• Drug Interactions Between Morphine and Orally or IV Administered AcetaminophenCompletedNCT02848729Phase 4Results posted
• Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1CompletedNCT02770716Phase 3Results posted
• Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional ConstipationCompletedNCT02766777Phase 3Results posted
• Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe PainTerminatedNCT02746263Phase 4Results posted
• EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT02724644Phase 2Results posted
• Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric SubjectsTerminatedNCT02687451Phase 3Results posted
• Reduction in Pain Intensity Following IV or Oral Pain-relieving ProductsCompletedNCT02678416Phase 4Results posted
• Acthar for Treatment-Resistant or Treatment-Intolerant ProteinuriaCompletedNCT02633046Phase 4Results posted
• Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel SyndromeTerminatedNCT02544152Phase 2Results posted
• Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute PainTerminatedNCT02508935Phase 4Results posted
• Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain PatientsTerminatedNCT02321319Phase 3Results posted
• Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease NodulesCompletedNCT02193828Phase 2Results posted
• Lubiprostone for Children With ConstipationCompletedNCT02138136Phase 3Results posted
• Topical Raplixa for Surgical Bleeding in ChildrenTerminatedNCT02117349Phase 2Results posted
• Lubiprostone in Children With Functional ConstipationCompletedNCT02042183Phase 3Results posted
• Clinical Study for the Treatment of Adhesive Capsulitis of the ShoulderCompletedNCT02006719Phase 2Results posted
• Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic ConstipationCompletedNCT01993875Phase 3Results posted
• A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic PanniculopathyCompletedNCT01987986Phase 2Results posted
• Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)CompletedNCT01966419Phase 2Results posted
• A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral SclerosisCompletedNCT01906658Phase 2Results posted
• Stannsoporfin With Light Therapy for Newborn Babies With JaundiceCompletedNCT01887327Phase 2Results posted
• Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active DiseaseCompletedNCT01753401Phase 4Results posted
• A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's DiseaseCompletedNCT01685437Phase 3Results posted
• Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's ContracturesCompletedNCT01674634Phase 3Results posted
• A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric PatientsCompletedNCT01635101Phase 3Results posted
• Acthar for Treatment of Proteinuria in Diabetic Nephropathy PatientsCompletedNCT01601236Phase 2Results posted
• A Study of Fibrocaps™ in Surgical BleedingCompletedNCT01527357Phase 3Results posted
• Retreatment of Recurrent Dupuytren's ContracturesCompletedNCT01498640Phase 4Results posted
• Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label ExtensionCompletedNCT01484652Phase 3Results posted
• AA4500 for the Treatment of Adhesive Capsulitis of the ShoulderCompletedNCT01483963Phase 2Results posted
• Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back PainCompletedNCT01451385Phase 3Results posted
• StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness BurnsCompletedNCT01437852Phase 1Results posted
• Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's DiseaseCompletedNCT01430169Phase 2Results posted
• Administration of Two Injections for Multiple Dupuytren's ContracturesCompletedNCT01407068Phase 3Results posted
• Acthar for Treatment of Proteinuria in Membranous Nephropathy PatientsCompletedNCT01386554Phase 4Results posted
• Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)CompletedNCT01380535Early Phase 1Results posted
• Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the BladderTerminatedNCT01310803Phase 3Results posted
• Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)CompletedNCT01298219Phase 3Results posted
• A Study of Fibrocaps in Liver Surgery in the NetherlandsCompletedNCT01256190Phase 2Results posted
• U.S. Study of Fibrocaps in Surgical HemostasisCompletedNCT01256164Not applicableResults posted
• A Study of AA4500 in Men With Peyronie's DiseaseCompletedNCT01243411Phase 3Results posted
• Time to Eugonadal Range, Time to Steady State and Drying TimeCompletedNCT01228071Phase 3Results posted
• Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221623Phase 3Results posted
• Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221597Phase 3Results posted
• Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric SubjectsCompletedNCT01210352Phase 3Results posted
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With TerlipressinCompletedNCT01143246Phase 3Results posted
• Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee OsteoarthritisCompletedNCT01119898Phase 2Results posted
• Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)CompletedNCT00955110Phase 4Results posted
• Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm InfantsCompletedNCT00931632Phase 3Results posted
• Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal FunctionTerminatedNCT00879645Phase 1Results posted
• A Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaTerminatedNCT00850993Phase 2Results posted
• Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.CompletedNCT00801398Phase 3Results posted
• Histrelin Subcutaneous Implant in Children With Central Precocious PubertyCompletedNCT00779103Phase 3Results posted
• Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric SubjectsTerminatedNCT00765856Phase 3Results posted
• The Safety and Effectiveness of AA4500 in Subjects With Peyronie's DiseaseCompletedNCT00755222Phase 2Results posted
• Efficacy and Safety of Cobiprostone in Patients With Portal HypertensionTerminatedNCT00737594Phase 2Results posted
• Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight LossCompletedNCT00637572Phase 2Results posted
• A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) PainCompletedNCT00631319Phase 3Results posted
• Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator TestingCompletedNCT00626028Phase 3Results posted
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of LubiprostoneCompletedNCT00620061Phase 3Results posted
• StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin DefectsCompletedNCT00618839Phase 1/2Results posted
• Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult SubjectsCompletedNCT00608959Phase 3Results posted
• Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric InpatientsCompletedNCT00598702Phase 3Results posted
• Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult InpatientsCompletedNCT00598559Phase 3Results posted
• Cobiprostone Prevention of NSAID-induced Gastroduodenal InjuryCompletedNCT00597818Phase 2Results posted
• Opioid-induced Bowel Dysfunction Pivotal Assessment of LubiprostoneCompletedNCT00597428Phase 3Results posted

← Keenova Therapeutics plc overview and focus areas